http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022008634-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f1c1c764dd679fb14a4758cfa8a0a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab046c66a44f69970a81f1736d128e18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb508d8feff4365d8d7db9b82dcc6f3e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-876
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fa8ce70369cda3810420361eed085e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db63c4e34223901e39c2425176d288f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ee14009cf992313a85d69eb3dc0108
publicationDate 2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022008634-A1
titleOfInvention Tumor-associated peptides and uses thereof
abstract The present invention provides antigen presenting cells (APC) carrying human tumor- associated peptides on the cell surface as well as immunogenic compositions comprising the tumor-associated peptides and/or the antigen presenting cells according to the invention. The immunogenic composition of the invention is useful as a vaccine in the prevention and/or treatment of a tumor disease, particularly melanoma and melanoma residual disease.
priorityDate 2020-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015022530-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004050860-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017081286-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03087831-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020058277-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013175256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012040602-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006091861-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18598300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57472993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040

Total number of triples: 50.